Search

Your search keyword '"Maurici D"' showing total 81 results

Search Constraints

Start Over You searched for: Author "Maurici D" Remove constraint Author: "Maurici D"
81 results on '"Maurici D"'

Search Results

6. Carcinogenicity

7. Genotoxicity and mutagenicity

8. Modulation of different stress pathways after styrene and styrene-7,8-oxide exposure in HepG2 cell line and normal human hepatocytes

22. Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: A possible therapeutic target

23. Establishment and characterization of multidrug-resistant human osteosarcoma cell lines

27. Clinical relevance of Ki-67 expression in bone tumors

29. Editorial: Exploring the need to include microbiomes into EFSA's scientific assessments

30. Modulation of different stress pathways after styrene and styrene-7,8-oxide exposure in HepG2 cell line and normal human hepatocytes

31. Guidance on aneugenicity assessment.

32. Editorial: Exploring the need to include microbiomes into EFSA's scientific assessments.

33. Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on the genotoxic potential of triazine amine (metabolite common to several sulfonylurea active substances).

34. Genotoxicity assessment of chemical mixtures.

35. Clarification of some aspects related to genotoxicity assessment.

36. Genotoxicity testing approaches for the safety assessment of substances used in food contact materials prior to their authorization in the European Union.

37. Scientific motivations and criteria to consider updating EFSA scientific assessments.

38. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.

39. Modulation of different stress pathways after styrene and styrene-7,8-oxide exposure in HepG2 cell line and normal human hepatocytes.

40. Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use.

41. Genotoxicty and mutagenicity.

42. Carcinogenicity.

43. The tumor suppressor gene TP53: implications for cancer management and therapy.

44. New insights into the mechanisms involved in renal proximal tubular damage induced in vitro by ochratoxin A.

45. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.

46. Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1.

47. Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay.

48. Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia.

49. The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells.

50. Cytologic and fluorescence in situ hybridization (FISH) examination of metanephric adenoma.

Catalog

Books, media, physical & digital resources